Last reviewed · How we verify
NCT07530965
OMEGA-3-FATTY ACIDS IN CHILDREN WITH SICKLE CELL DISEASE
NA trial testing Flaxseed in Sickle Cell Disease (SCD) in 20 participants. Not yet recruiting.
31 December 2027
Quick facts
| Lead sponsor | University of Alabama at Birmingham |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 1 June 2026 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2028 |
Drugs / interventions tested
- Flaxseed — full drug profile →
Conditions studied
- Sickle Cell Disease (SCD) — all drugs for Sickle Cell Disease (SCD) →
Sponsor
University of Alabama at Birmingham
Who can join
Adults 5 to 18, any sex, with Sickle Cell Disease (SCD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this feasibility study is to investigate the role of a dietary supplement in modulating the gut microbiota and improving pain outcomes in children with sickle cell disease (SCD).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07530965
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Flaxseed
Trials testing the same drug.
- NCT05245825 — Flaxseed Supplementation in Prediabetic Adults (LINAPRED) · NA · unknown
- NCT03915600 — Efect of Quinoa and Flaxseed in Cititoxicity and Glicemic Control in Metabolic Syndrome Patients · NA · unknown
- NCT04024605 — Bioavailability of Protein and Amino Acids From Oilseeds in Healthy Volunteers · NA · unknown
- NCT03183102 — The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator. · NA · completed
- NCT03392025 — Flaxseed Consumption, Alone and in Combination With the Mediterranean-like Diet, on Some Indicators Related to Atheroscl · NA · completed
Other recruiting trials for Sickle Cell Disease (SCD)
Currently open trials in the same condition.
- NCT06619197 — Exploratory Study on Global Reflexology in Sickle Cell Disease · NA · recruiting
- NCT06887907 — Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient · recruiting
- NCT06941389 — Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therap · recruiting
- NCT03814746 — Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients · Phase 3 · active not recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
- NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
- NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
- NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
- NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
- NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07530965 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
- Last refreshed: 15 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07530965.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing